Acute Effects of Patellar Tendon Ultrasound on Countermovement Jump Performance

March 27, 2026 updated by: Muş Alparslan University

Acute Effects of Therapeutic Ultrasound Applied to the Patellar Tendon on Countermovement Jump Performance: A Randomized Controlled Trial

This randomized, double-blind, controlled trial aims to investigate the acute effects of therapeutic ultrasound applied to the patellar tendon on vertical jump performance in healthy university students. Therapeutic ultrasound is widely used in physiotherapy to influence soft tissue properties through thermal and mechanical effects; however, its immediate impact on explosive lower-extremity performance and neuromuscular function remains unclear.

Participants will be randomly assigned to either a therapeutic ultrasound group or a sham ultrasound (placebo) group. In the intervention group, therapeutic ultrasound will be applied to the patellar tendon using a frequency of 1 MHz and an intensity of 1.5 W/cm² in continuous mode for 5 minutes. In the control group, a sham ultrasound procedure will be performed using the same device and duration without delivering therapeutic energy. Both the participants and the outcome assessor will be blinded to group allocation.

Vertical jump performance will be evaluated using the countermovement jump (CMJ) test recorded with the My Jump 2 smartphone application. In addition, quadriceps muscle strength will be measured using a hand-held dynamometer, and knee joint position sense will be assessed using a joint position reproduction test. All measurements will be conducted before and immediately after the intervention.

This study will provide evidence regarding whether therapeutic ultrasound applied to the patellar tendon can acutely influence explosive performance, muscle strength, and proprioception in healthy individuals.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

This randomized, double-blind, controlled trial aims to investigate the acute effects of therapeutic ultrasound applied to the patellar tendon on vertical jump performance, quadriceps muscle strength, and knee joint proprioception in healthy university students. Therapeutic ultrasound is a commonly used physiotherapy intervention that can induce thermal and mechanical effects on soft tissues; however, its immediate impact on explosive lower-extremity performance and neuromuscular function has not been fully established.

A total of healthy participants aged 18-35 years will be recruited and screened according to predefined inclusion and exclusion criteria. Eligible participants will be randomly assigned to either a therapeutic ultrasound group or a sham (placebo) ultrasound group. The intervention group will receive therapeutic ultrasound applied to the patellar tendon at a frequency of 1 MHz, intensity of 1.5 W/cm², in continuous mode for 5 minutes. The sham group will undergo the same procedure without delivery of therapeutic energy. Both participants and the outcome assessor will be blinded to group allocation, ensuring a double-blind design.

Outcome measures will be recorded immediately before and within one minute after the intervention. Vertical jump performance will be assessed using the countermovement jump (CMJ) recorded with the My Jump 2 smartphone application. Quadriceps muscle strength will be measured using a hand-held dynamometer, and knee joint position sense will be evaluated using a joint position reproduction test. Participants will perform three trials for each measure, with 60-second rest intervals between trials, and the best value will be used for analysis. Familiarization trials will be conducted prior to testing to minimize learning effects.

This study will provide evidence on whether therapeutic ultrasound applied to the patellar tendon can acutely influence explosive performance, quadriceps strength, and proprioception in healthy individuals, which may inform clinical and sports performance applications.

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy university students aged 18-35 years
  • No history of lower extremity injury or surgery in the past 12 months
  • No current musculoskeletal or neurological disorders affecting the lower limbs

Exclusion Criteria:

  • History of patellar tendon injury or knee pain
  • Contraindications to therapeutic ultrasound (e.g., skin lesions, open wounds at the knee, or implanted electronic devices)
  • Any cardiovascular, neurological, or musculoskeletal condition that may affect jump performance
  • Use of medications that could affect neuromuscular function (e.g., muscle relaxants)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Ultrasound Group
The use of therapeutic ultrasound in healthy individuals
The use of therapeutic ultrasound on the patellar tendon in healthy individuals.
Sham Comparator: sham Group
Use of sham ultrasound in healthy individuals
The use of therapeutic ultrasound on the patellar tendon in healthy individuals.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Countermovement Jump Height
Time Frame: Immediately before and immediately after the intervention (within 1 minute following the ultrasound or sham ultrasound application)
Vertical jump performance will be assessed using the countermovement jump (CMJ) test recorded with the My Jump 2 smartphone application. Participants will perform three maximal jumps with their hands placed on their hips to eliminate arm swing, and the highest jump height (cm) will be used for analysis.
Immediately before and immediately after the intervention (within 1 minute following the ultrasound or sham ultrasound application)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knee Joint Position Sense
Time Frame: Immediately before and immediately after the intervention
Knee joint position sense will be assessed using a joint position reproduction test to evaluate proprioception. Participants will actively reproduce a predetermined knee flexion angle without visual feedback, and the absolute angular error (degrees) between the target and reproduced position will be recorded.
Immediately before and immediately after the intervention
Quadriceps Muscle Strength
Time Frame: Immediately before and immediately after the intervention
Quadriceps muscle strength will be measured using a hand-held dynamometer. Participants will perform maximal voluntary isometric knee extension while seated with the knee flexed at 90 degrees. The highest value obtained from three trials will be recorded in kilograms (kg) for analysis.
Immediately before and immediately after the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Burhan TAŞKAYA, Muş Alparslan University
  • Principal Investigator: Cengiz TAŞKAYA, Muş Alparslan University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 20, 2026

Primary Completion (Estimated)

April 27, 2026

Study Completion (Estimated)

May 1, 2026

Study Registration Dates

First Submitted

March 27, 2026

First Submitted That Met QC Criteria

March 27, 2026

First Posted (Actual)

April 2, 2026

Study Record Updates

Last Update Posted (Actual)

April 2, 2026

Last Update Submitted That Met QC Criteria

March 27, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • Therapeutic Ultrasound

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Muscle Performance

Clinical Trials on therapeutic ultrasound Group

Subscribe